(Q44438551)

English

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases

scientific article published on May 15, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Progesterone Receptor Status Significantly Improves Outcome Prediction Over Estrogen Receptor Status Alone for Adjuvant Endocrine Therapy in Two Large Breast Cancer Databases (English)

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

2

object named as

Grazia Arpino

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743151

1 January 2024

author name string

Valerie-Jeanne Bardou

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Richard M. Elledge

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743151

1 January 2024

C. Kent Osborne

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743151

1 January 2024

Gary M. Clark

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743151

1 January 2024

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

15 May 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12743151

1 January 2024

full work available at URL

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2003.09.099

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1973-1979

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Prognostic factors for recurrence and survival in human breast cancer

1

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity

3

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

4

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Specific progesterone receptors in human breast cancer

5

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study

6

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study

7

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

10

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Nonparametric Estimation from Incomplete Observations

11

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Asymptotically Efficient Rank Invariant Test Procedures

12

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Regression Models and Life-Tables (with discussion)

13

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Estrogen receptors and long-term prognosis in breast cancer

14

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Prognostic value of estrogen receptors in primary breast cancer

15

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Time-dependence of hazard ratios for prognostic factors in primary breast cancer

16

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Time-dependent relevance of steroid receptors in breast cancer

17

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Results of two or five years of adjuvant tamoxifen correlated to steroid receptor and S-phase levels

18

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial

19

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer

20

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Hormone dependency in N-nitrosomethylurea-induced rat mammary tumors

21

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis

22

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Breast cancer prognostic factors: evaluation guidelines.

23

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer

25

1 reference

10.1200/JCO.2003.09.099

https://api.crossref.org/works/10.1200/JCO.2003.09.099

1 January 2024

Identifiers

10.1200/JCO.2003.09.099

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44438551&oldid=2042579668"